Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma – a Window Study
Condition(s):Hodgkin LymphomaLast Updated:December 12, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Hodgkin LymphomaLast Updated:December 12, 2023Active, not recruiting
Condition(s):Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms; Testicular Diseases; Gonadal Disorders; Antineoplastic Agents; Molecular Mechanisms of Pharmacological ActionLast Updated:March 5, 2019Completed
Condition(s):Triple Negative Breast Cancer; Locally Advanced Breast Cancer; Recurrent Breast Cancer; Metastatic Breast Cancer; ER+ Breast Cancer; HER2-positive Breast CancerLast Updated:December 22, 2023Recruiting
Condition(s):CancerLast Updated:February 25, 2022Completed
Condition(s):Urothelial CarcinomaLast Updated:April 18, 2023Withdrawn
Condition(s):Recurrent Respiratory Papillomatosis; Juvenile Laryngeal Papilloma; Laryngeal Papilloma, Recurrent; Respiratory Papillomatosis; Human Papilloma VirusLast Updated:November 2, 2021Completed
Condition(s):Metastatic Colorectal CancerLast Updated:April 3, 2020Unknown status
Condition(s):Metastatic Cancer; Urothelial CarcinomaLast Updated:May 9, 2023Recruiting
Condition(s):CancerLast Updated:March 7, 2024Active, not recruiting
Condition(s):Leptomeningeal Metastases; Leptomeningeal DiseaseLast Updated:January 25, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.